ADA and COVID-19: In another study, the nasopharyngeal specimen of SARS-CoV-2 infected patients revealed higher ADA expression level in nasopharyngeal swabs when compared with controls and, interestingly, when compared to the swabs obtained from patients with severe COVID-19 [60].